BIO-key International Inc. (NASDAQ:BKYI) Short Interest Update

BIO-key International Inc. (NASDAQ:BKYI) was the recipient of a significant drop in short interest during the month of July. As of July 15th, there was short interest totaling 1,399 shares, a drop of 68.4% from the June 30th total of 4,425 shares. Currently, 0.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 34,947 shares, the short-interest ratio is presently 0.0 days.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of BIO-key International in a research report on Friday, July 17th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.

Institutional Inflows and Outflows

A hedge fund recently raised its position in BIO-key International stock. Geode Capital Management LLC lifted its holdings in BIO-key International Inc. (NASDAQ:BKYI) by 49.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 48,892 shares of the technology company’s stock after purchasing an additional 16,271 shares during the quarter. Geode Capital Management LLC owned 0.45% of BIO-key International worth $26,000 at the end of the most recent quarter. 26.51% of the stock is currently owned by hedge funds and other institutional investors.

BIO-key International Trading Down 0.6%

Shares of NASDAQ:BKYI traded down $0.03 during mid-day trading on Tuesday, reaching $4.72. The stock had a trading volume of 2,431,762 shares, compared to its average volume of 169,115. The business’s 50 day moving average price is $4.48 and its 200 day moving average price is $5.42. BIO-key International has a 1 year low of $3.10 and a 1 year high of $19.70. The company has a market cap of $5.15 million, a P/E ratio of -0.85 and a beta of 0.43.

About BIO-key International

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.